Globeflex Capital L P Xeris Biopharma Holdings, Inc. Transaction History
Globeflex Capital L P
- $592 Million
- Q3 2025
A detailed history of Globeflex Capital L P transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 123,184 shares of XERS stock, worth $893,084. This represents 0.17% of its overall portfolio holdings.
Number of Shares
123,184
Previous 80,431
53.15%
Holding current value
$893,084
Previous $375,000
165.87%
% of portfolio
0.17%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
225Shares Held
92.4MCall Options Held
107KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$27.8 Million0.01% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...